<DOC>
	<DOCNO>NCT00860366</DOCNO>
	<brief_summary>The purpose study determine whether combined treatment Uric Acid rtPA superior rtPA alone term clinical efficacy acute ischemic stroke patient treat within first 4.5 hour symptoms onset .</brief_summary>
	<brief_title>Efficacy Study Combined Treatment With Uric Acid rtPA Acute Ischemic Stroke</brief_title>
	<detailed_description>Oxidative stress major contributor brain damage patient ischemic stroke . Uric acid ( UA ) endogenous product derive metabolism purins man responsable 60 % total antioxidant capacity organism . Recent experimental evidence gather research group show exogenous administration UA neuroprotective cortical subcortical brain area result antioxidant property . In study , animal treat UA disclose small brain infarction transient focal ischemia , use intraluminal model injection autologous clot . Moreover , group first describe great neuroprotection animal pretreated rtPA ( alteplase ) . Likewise , recently show administration UA free serious adverse effect stroke patient receive rtPA within 3 hour stroke onset . Yet , preliminary data suggest intervention might translate clinical benefit 3 month follow-up . Based data , aim conduct phase 3 , randomize , double-blind , control trial assess clinical efficacy UA administration acute ischemic stroke patient . Currently , rtPA approve therapy stroke patient within first hour clinical onset , oxidative stress think particularly relevant follow ischemia/reperfusion . Based ground , aim conduct phase 3 clinical trial ischemic stroke patient currently treat rtPA within 4 ' 5 hour window .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Uric Acid</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Inclusion criterion : Age old 18 year old . Acute ischemic stroke treat rtPA within first 4.5 hour clinical onset . Baseline National Institute Health Stroke Scale ( NIHSS ) &gt; 6 &lt; 25 , modify Rankin Scale ( mRS ) 2 prior stroke . Cranial CT disclose absence blood CNS . Informed consent . Exclusion criterion : Presence valid exclusion criterion administration rtPA current clinical practise . History gout without history gouty nephropathy , uric lithiasis . Asymptomatic hiperuricemia chronic treatment allopurinol , chronic treatment lithium . Chronic renal insufficiency ( baseline creatinine &gt; 1,5mg/dl ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Acute ischemic stroke</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>alteplase</keyword>
	<keyword>uric acid</keyword>
	<keyword>neuroprotection</keyword>
	<keyword>oxidative stress</keyword>
</DOC>